Gene search


Sequence information


Select Gene Cds Cds_length GC_content Pep Pep_length
Vifa4g01721 ATGATGTCTTCATCGTCTTCTTTGTCCGGTGGAGCATTCAGGCTTCGTTGGGATGTGTTTTTGAGTTTTAGAGGTGAAGACACTCGCCAATGCTTCACCAAAAAACTATACGAATCTCTCCACGGTCAAGGAGTTCGTGCTTTCATGGACGACGAGGGTTTGGACCGTGGGGATCGTATAGATATCACTCTTCTTCAAGCTATTGATGATTCTGCTGCTTCCATTGTTATTATCTCTCGTAATTACGCTGACTCTCATTGGTGTCTCGATGAACTTGTCAGGATTTTTGAATGCAAGAGGCTTGTTATTCCCGTTTTCTACAAAGTTGATCCTTCTCATGTTAGGAAACAGTCCGGCCCTTTTCAAAAAGGTTTTACTGATCTTGAAAACAGATTTGGTAATCTTATGGTTTCCAAGTGGAGACATTCTATGAAGTTACTTGGTGGACTTGCTGGCTTTGTTTTCAATGACAGTTATGAAGGCCAGCTTGAAAATCTGATACACCTTTTGGTGAAAAGGGTTTTGAAGGAGTTAAGTAATACTCCAATGGTTGTCGCTGAGTTTCTAGTCGGACTCAACCAACGTGTTGACAAGGTCATACATCTGTTACAACTTCAACCCAACAGCGTCAAGGTCTTAGGGTTGTATGGGATGGGAGGTGTTGGTAAGACAACACTTGCCAAGGCTCTTTTCAATACTCTCGTTGCTCGCTTTGAGCGTAGATGTTTCGTTTCAAATGTGAGAAACTCCTCGTCTAAAGAGGCTGGTTTGCTTTCTCTTCAAAGCAATATCATTAAAGATCTTTCTTCTCAACAAGGAGCTCAGAGTTTTGTAAGTGATGTCAATGCCGGTATTGCTACTATCAAAAGAATAGTTCATGAAAATCGAGTTCTGCTAGTGTTGGATGATGTTGATAATGTAAGCCAGCTTGATGCTTTGATTGGTAAAAGGGAATGGTTTTATAAAGGAAGCTGTATAATCATTACAACAAGGGACACGACTGCTTTGCCTGAAAAACATGTCAACCAGATGTATGAAGTCAAAGAATTGTATGATGAAGAAGCTCTACAATTATTCAGTTACCATGCTTTGAAGAAAAAGGACCCTCCACCAAGTTTTCTGGATCTTTCAAAGAAAATTGTATCTCTTACCGGAAGAATGCCATTGGCTTTGGAAGTGTTTGGTTGCTTTCTGTGTGAGAGAAGGAGGGTGGAGGAGTGGGAGGATGCTGTTGTGAAGCTGAGAACAATTCGACCCGGGAATCTTCATGATGTGTTGAAGATAAGTTATGATGGGTTGGACGAACAAGAGAAGTGTATATTCCTTGATATTGCTTGTTTCTTTCTTCAAATGGAAATGAAGCGCGGTGATGTGATTGATATATTGAGAGGTTGTGGGTTTAGAGGAGAGATAGCTATGACCATCCTTGTACAGAAATGCTTAATCAAAATAAAACATGACAATACCTTGTGGATGCATGATCAAATTAGAGACATGGGAAGACAGATTGTTATGGATGAAAACCATGTTGATCCTGGGATGCGAAGTAGACTGTGGGATCGTGCTGAAATCATGTCCGTTTTGAAGAGTAAGAAGGGAACAAGATGCGTACAAGGAATTGTACTAGACTTTAAGAAAAGATCAATCATTGTAGCAGAGAAATATAACTATGTTACACTTGATACAAAATCCTTTGAACCAATGGTTAACCTGAGATTGCTTCAGATCAATAATATGAGTTTGGAGGGCAAGTTTCTTCCAGATGAACTGAAATGGCTACAATGGCAAGGATGTCCTTTGGAGTGCATTCCTTTGGACACATTGCCACGTGAACTGGCTGTCCTTGATCTCTCAAATGCTGAGAAAATTAAGAGCTTGAGGGCATTGGAAAGTCACAACAAGGTACCAGAGAACCTAATGGTCATTAAACTCTCTGACTGCTACCGACTTGCTGCAATCCCTGACTTATCTAGGTGTCTCAGGCTGGAGAAAATTATTTTGGATAGCTGCATTAATCTCAAAAGGATTCATGAATCAATTGGCAGTTTGACTACCTTGCGTATTTTGAGCTTGAGGCGTTGTGAAAACATCACTGAGATTCCCAGTGATGTATCTGGGCTGAAACATCTGGAGAGCCTCGTTCTTTCTAATTGCACCAAGTTGAAAGCATTACCAGAAAGCATAGGCATGCTTAACTCGCTGAAAACACTTGAGGTGGTTGACACTGCTATAGTAAAGTTGCCCGAGTCTATTTTTCGCTTGACCAAACTCGAACGACTCGTTTTAGATCATTGCTCATATTTGAGAAGACTGCCAAACTGCATTGGAAAATTATGTTCACTGCAAGAATTATCTCTTAATCATTCAGGCTTACTAGAATTACACGACACTCTGGGATCCTTGATAAATCTTGAGAAGTTAAGTTTGATTTGGTGTGAATCTCTCACGGTAATGCCTGATTCTATAGGAAATCTCGTATCGTTGACAGAACTTTTAGCTTTCAACAGTGGAATTAAAGAACTTCCTTCCACCATTGGTTCTTTATCCAATCTGAGAATGTTATCAGTTGGAAACAGTAAACATCTCAGTAAATTGCCTGATTCAATTAAAACTCTGGCCTCAATTATTGAACTTAAGTTAGATGGAACACCCATCAAATATCTTCCTGATCAAATTGGAGAAATGAAACAACTAAGGAAGCTTGATATTGGGAATTGCAGCAATCTTGAATCATTACCAGAATCCATTGGCCACCTAGGATCTCTTACTTCGCTGAACATAAACAATGGAAATATCAAAGAATTACCAGTGTCAATTGGATTATTGGAAAATCTTGTTACCTTAACATTGAACAAATGTAGAATGCTTAAACACCTCCCAGCTTCTATAGGAAACTTAAAATCTCTATGTCACTTAAATATGGTGGAAACAACTATGTCAGACTTGCCTGAAAGTTTTGGTATGCTCTCAAGCTTGAGAACACTAAGAATGGGAAAGACGCCTAATTTAGTTCCCATATCTGTGGAGAACACGGGCTCTTTTGTGATACCGTCTTCTTTCTGTAATCTGACCTTGCTATCTGATTTCGATGCCCATGCCTGGGGATTATCTGGTAAAATTCCCGATGAATTCGAGAAGCTATCATTAATGGAGACTTTAAAATTGGGCCACAACAATTTCCACAGCCTTCCTTCCAGTTTGAAAGGTCTTTCCTTTCTCAAGAAACTCTTACTTCCAAATTGCACTGAGCTGACTTCTCTCCCCTCACTTCCTTCAAGCTTGATCGAGCTAAACGCTGATAATTGCTACGCATTAGAAACTATACACGACATGTCAAATTTAGAGAGTTTGGAGGAGTTGAAACTCACAAATTGTGGGAAAGTGGCGGATATTCCAGGTCTTGAATGCTTGAAGTCCTTGAGAAGATTGTACCTGAGTGGTTGCCATGCATGCTCCTCCAAAGTACGCAAAAGACTTTCAAAGGTTGCACTGAGAAATTTTCAGAACTTGAGCATGCCAGGAACCAAATTACCTGAATGGTTTTCGGGAGAAACTGTAAACTTTACCAAGCGCAAAAATCTTGAGCTAAAAAGTGTAGTTGTAGGTGTTATTTTCTCAATTAACCACAACAATATGAAAAATCAAATCCCCGATGTGGTTGATATTCAAGCAAAGGTCCTCAAATCAGGCGAACAAGTTTTTAGTTCAGTGTTATTCATAGGTGGGGTGCCAAGGACAAATGAACCACAAATACACTTGCGAAGGTTCCATGATTACCATGCATTGCGAAGGGAGTTAAAAGAAGCTGATACGGTTTGTGTGGCAAAGCGAAGTCCTCCTTTTGATGAGAGGTTGGAATTGATAAAATCTGGAATTCATTTAATCTTTGAAGGGGATGATGATTATGAGGGAGACGAAGAATCGTTGGACAAAGGCCTACAATCTGTCTCAGAAAGGATAGCCAGGTTTTTTAACACTTATGATGAAGGTGTTGATGCAACTGAGAATGAAGATAAGTGTCAACATGGATTGGAGCAGGTAAAAGAAAAGCCTCGAACTAGATTACTTGGTGTTAAAGGCAATTCTATTATTCTCTTCCTGTTTAATCTATTCTTTGTGCTGTTGGGTTGGTTTTGGTTGAGATATATGTCAAGTGTTGAAAGAAGAGATTGA 4173 0.3971 MMSSSSSLSGGAFRLRWDVFLSFRGEDTRQCFTKKLYESLHGQGVRAFMDDEGLDRGDRIDITLLQAIDDSAASIVIISRNYADSHWCLDELVRIFECKRLVIPVFYKVDPSHVRKQSGPFQKGFTDLENRFGNLMVSKWRHSMKLLGGLAGFVFNDSYEGQLENLIHLLVKRVLKELSNTPMVVAEFLVGLNQRVDKVIHLLQLQPNSVKVLGLYGMGGVGKTTLAKALFNTLVARFERRCFVSNVRNSSSKEAGLLSLQSNIIKDLSSQQGAQSFVSDVNAGIATIKRIVHENRVLLVLDDVDNVSQLDALIGKREWFYKGSCIIITTRDTTALPEKHVNQMYEVKELYDEEALQLFSYHALKKKDPPPSFLDLSKKIVSLTGRMPLALEVFGCFLCERRRVEEWEDAVVKLRTIRPGNLHDVLKISYDGLDEQEKCIFLDIACFFLQMEMKRGDVIDILRGCGFRGEIAMTILVQKCLIKIKHDNTLWMHDQIRDMGRQIVMDENHVDPGMRSRLWDRAEIMSVLKSKKGTRCVQGIVLDFKKRSIIVAEKYNYVTLDTKSFEPMVNLRLLQINNMSLEGKFLPDELKWLQWQGCPLECIPLDTLPRELAVLDLSNAEKIKSLRALESHNKVPENLMVIKLSDCYRLAAIPDLSRCLRLEKIILDSCINLKRIHESIGSLTTLRILSLRRCENITEIPSDVSGLKHLESLVLSNCTKLKALPESIGMLNSLKTLEVVDTAIVKLPESIFRLTKLERLVLDHCSYLRRLPNCIGKLCSLQELSLNHSGLLELHDTLGSLINLEKLSLIWCESLTVMPDSIGNLVSLTELLAFNSGIKELPSTIGSLSNLRMLSVGNSKHLSKLPDSIKTLASIIELKLDGTPIKYLPDQIGEMKQLRKLDIGNCSNLESLPESIGHLGSLTSLNINNGNIKELPVSIGLLENLVTLTLNKCRMLKHLPASIGNLKSLCHLNMVETTMSDLPESFGMLSSLRTLRMGKTPNLVPISVENTGSFVIPSSFCNLTLLSDFDAHAWGLSGKIPDEFEKLSLMETLKLGHNNFHSLPSSLKGLSFLKKLLLPNCTELTSLPSLPSSLIELNADNCYALETIHDMSNLESLEELKLTNCGKVADIPGLECLKSLRRLYLSGCHACSSKVRKRLSKVALRNFQNLSMPGTKLPEWFSGETVNFTKRKNLELKSVVVGVIFSINHNNMKNQIPDVVDIQAKVLKSGEQVFSSVLFIGGVPRTNEPQIHLRRFHDYHALRRELKEADTVCVAKRSPPFDERLELIKSGIHLIFEGDDDYEGDEESLDKGLQSVSERIARFFNTYDEGVDATENEDKCQHGLEQVKEKPRTRLLGVKGNSIILFLFNLFFVLLGWFWLRYMSSVERRD 1390
       

Annotation information


Select Seq ID Length Analysis Description Start End IPR GO
Vifa4g01721 1390 Gene3D - 15 177 IPR035897 -
Vifa4g01721 1390 Gene3D Ribonuclease Inhibitor 741 834 IPR032675 -
Vifa4g01721 1390 SUPERFAMILY P-loop containing nucleoside triphosphate hydrolases 180 444 IPR027417 -
Vifa4g01721 1390 Gene3D - 349 434 IPR042197 -
Vifa4g01721 1390 PRINTS Disease resistance protein signature 291 305 - -
Vifa4g01721 1390 PRINTS Disease resistance protein signature 893 909 - -
Vifa4g01721 1390 PRINTS Disease resistance protein signature 384 398 - -
Vifa4g01721 1390 PRINTS Disease resistance protein signature 212 227 - -
Vifa4g01721 1390 PANTHER LEUCINE-RICH REPEAT-CONTAINING PROTEIN 18 773 IPR044974 GO:0006952
Vifa4g01721 1390 SUPERFAMILY L domain-like 889 1179 - -
Vifa4g01721 1390 Pfam TIR domain 17 158 IPR000157 GO:0007165
Vifa4g01721 1390 Pfam NB-ARC domain 194 418 IPR002182 GO:0043531
Vifa4g01721 1390 SUPERFAMILY Toll/Interleukin receptor TIR domain 14 152 IPR035897 -
Vifa4g01721 1390 Gene3D Ribonuclease Inhibitor 554 732 IPR032675 -
Vifa4g01721 1390 Gene3D Ribonuclease Inhibitor 835 1009 IPR032675 -
Vifa4g01721 1390 Gene3D Ribonuclease Inhibitor 1010 1218 IPR032675 -
Vifa4g01721 1390 SMART LRR_typ_2 683 707 IPR003591 -
Vifa4g01721 1390 SMART LRR_typ_2 872 895 IPR003591 -
Vifa4g01721 1390 SMART LRR_typ_2 1047 1069 IPR003591 -
Vifa4g01721 1390 SMART LRR_typ_2 825 848 IPR003591 -
Vifa4g01721 1390 SMART LRR_typ_2 778 801 IPR003591 -
Vifa4g01721 1390 SMART LRR_typ_2 919 942 IPR003591 -
Vifa4g01721 1390 SMART LRR_typ_2 731 754 IPR003591 -
Vifa4g01721 1390 Gene3D - 178 344 IPR027417 -
Vifa4g01721 1390 SMART LRR_CC_2 683 713 IPR006553 -
Vifa4g01721 1390 SMART LRR_CC_2 1114 1140 IPR006553 -
Vifa4g01721 1390 SMART LRR_CC_2 801 828 IPR006553 -
Vifa4g01721 1390 SMART LRR_CC_2 895 922 IPR006553 -
Vifa4g01721 1390 SMART till_3 16 150 IPR000157 GO:0007165
Vifa4g01721 1390 SUPERFAMILY L domain-like 491 907 - -
Vifa4g01721 1390 ProSiteProfiles TIR domain profile. 15 158 IPR000157 GO:0007165
       

Duplication type information


Select Gene Chromosome Start End Duplicated_type
Vifa4g01721 Vifa-Chr4 488453261 488458641 Dispersed/Tandem
       

Functional genes information


Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Vifa4g01721 781 995 WRKY Transcription Factor Family AT4G12020 30.093 1.20e-07 54.7
       

Pathway information


Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Vifa4g01721 - - mtr:11408681 2058.49